Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2008
11/13/2008WO2008100547A3 Compositions comprising lamiridosin, iridoids or derivatives thereof for treatment of hepatitis c or hepatitis b
11/13/2008WO2008082562A3 Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
11/13/2008WO2008068631A3 Vaccines including antigen from four strains of influenza virus
11/13/2008US20080281236 Devices and methodologies useful in body aesthetics
11/13/2008US20080280968 Bactericides; vision defects; diphtheria; Escherichia; skin disorders; Lyme disease; drug resistant Staphylococcus; respiratory system disorders; pneumonia; sepsis; urogenital disorders;trtanus; toxic shock syndrome; diarrhea; tuberculosis; typhoid; malaria; antiprotozoa agents
11/13/2008US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents
11/13/2008US20080280965 Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)
11/13/2008US20080280964 Novel Antibiotics Comprising Bis(1-Aryl-5-Tetrazolyl)Methane Derivatives
11/13/2008US20080280963 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/13/2008US20080280961 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/13/2008US20080280945 Crystalline forms of an HIV integrase inhibitor
11/13/2008US20080280926 Phosphodiesterase Inhibitors
11/13/2008US20080280925 Amines as Small Molecule Inhibitors
11/13/2008US20080280892 Tricyclic nitrogen antibacterial; 1-({4-[(2,3-Dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-piperidinyl}methyl)-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one; may be used with other active ingredients, diluents
11/13/2008US20080280881 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
11/13/2008US20080280879 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
11/13/2008US20080280850 administering an effective viriuses treatment amount of a base-modified nucleoside or a salt or prodrug for treating a host infected with flavivirus, pestivirus or hepacivirus
11/13/2008US20080280849 Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents
11/13/2008US20080280846 2', 3'-dideoxynucleoside analogues for the treatment or prevention of flaviviridae infections
11/13/2008US20080280842 Fluorinated Pyrrolo[2,3-D]Pyrimidine Nucleosides for the Treatment of Rna-Dependent Rna Viral Infection
11/13/2008US20080280841 Amorphous Telithromycin Compound
11/13/2008US20080280833 amino acid motif GAAG; polypeptide that inhibits cell migration, cell adhesion, cell proliferation and/or cell differentiation; anticancer; adenocarcinoma, leukemia, lymphoma, or myeloma; inhibitor of chemotaxis
11/13/2008US20080280823 Treatment of Non-Alcoholic Steatotic Hepatitis (Nash)
11/13/2008US20080280354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
11/13/2008US20080280308 G protein coupled receptor signaling modulation
11/13/2008US20080279957 Pure extract from bovine bile; stimulant for monocytes and macrophages; in vitro; moderate tumor necrosis factor production; nontoxic to human blood cells; Aids therapy ; anticancer agents; multiple sclerosis; antiarthritic agents; lupus; antidiabetic agents; Crohn's disease; myasthenia gravis
11/13/2008US20080279929 Nanoparticulate and Controlled Release Compositions Comprising Cefditoren
11/13/2008US20080279920 Compositions For Treating Respiratory Viral Infections and Their Use
11/13/2008US20080279917 Bisbenzamidines for the Treatment of Pneumonia
11/13/2008US20080279892 Attenuation of respiratory syncytial virus by mutagenisi of M2-1 gene; immunogenic composition
11/13/2008US20080279890 Viral antigens
11/13/2008US20080279889 Administering porcine circovirus type 2 antigen; antiulcer gents; nephritis, sexual and urogenital disorders
11/13/2008US20080279887 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug.
11/13/2008US20080279886 recombinant virus that substantially lacks a phosphoprotein gene that is not required for growth of the virus in cultured cells but is important for establishing a latent infection
11/13/2008US20080279879 Therapeutic mixture for boosting cross-clade human immunodeficiency viral envelope protein specific immunoglobulin; immunotherapy
11/13/2008US20080279878 Compositions of Hsp60 Peptides and Viral Antigens for Vaccination and Diagnosis
11/13/2008US20080279863 Using polyclonal goose antibodies as therapeutic tool in preventing viral infection of birds and mammals
11/13/2008US20080279852 Methods of treatment with glycosylated antibodies
11/13/2008US20080279847 Tumor-associated glycoprotein-72 specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
11/13/2008US20080279844 Methods for Treating Cancer Targeting Transglutaminase
11/13/2008US20080279823 Modified cytokine for use in tredatment and prevention of autoimmune, cell proliferative targeting and infectious disorders
11/13/2008US20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand
11/13/2008US20080279816 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity; multiple sclerosis
11/13/2008US20080279812 Disease Prevention and Vaccination Prior to Thymic Reactivation
11/13/2008US20080276568 Building structure and components thereof
11/13/2008CA2727939A1 Methods and compositions for use of cyclic analogues of histatin
11/13/2008CA2703018A1 Methods of treating fungal infections
11/13/2008CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008CA2687395A1 Complement factor h-derived short consensus repeat-antibody constructs
11/13/2008CA2686138A1 Novel macrocyclic inhibitors of hepatitis c virus replication
11/13/2008CA2686051A1 Combination therapy for the treatment of hcv infection
11/13/2008CA2685805A1 Klebsiella antigens
11/13/2008CA2685506A1 Vaccine
11/13/2008CA2684922A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008CA2684503A1 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
11/13/2008CA2674831A1 5,6-ring annulated indole derivatives and methods of use thereof
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990410A1 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND
11/12/2008EP1990342A1 Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
11/12/2008EP1988972A2 Proteasom or ups inhibitor for treating infections with influenza viruses
11/12/2008EP1988903A2 Methods of maintaining oral health in animals using morpholine derivatives
11/12/2008EP1988884A2 Antiviral drugs for treatment of arenavirus infection
11/12/2008EP1988776A2 Antiviral drugs for treatment of arenavirus infection
11/12/2008EP1799696B1 Phosphoindoles as hiv inhibitors
11/12/2008EP1523582B1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
11/12/2008EP1478738B1 Anti-ccr5 antibody
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1472278B1 Macrocyclic peptides active against the hepatitis c virus
11/12/2008EP1404305B1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient
11/12/2008EP1392831B1 Moraxella(branhamella) catarrhalis antigens
11/12/2008EP1232184B1 Antibody against the human toll-like receptor-2 (tlr2) and uses thereof
11/12/2008EP1204421B1 Stress protein-peptide complexes as vaccines against intra-cellular pathogens
11/12/2008EP1064551B1 Development of human monoclonal antibodies and uses thereof
11/12/2008EP1014969B1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
11/12/2008EP0792359B1 Transcription factor e2f-4
11/12/2008EP0750668B1 Novel muteins of ifn-beta
11/12/2008CN101305095A Inhibition of viral gene expression using small interfering RNA
11/12/2008CN101305019A New cyclic peptide compounds
11/12/2008CN101305008A Tetracyclic indole derivatives as antiviral agents
11/12/2008CN101304995A Thiazole derivatives and use thereof
11/12/2008CN101304987A Aminophenylsulfonamide derivatives as HIV protease inhibitor
11/12/2008CN101304762A Compositions and methods for treating or preventing flaviviridae infections
11/12/2008CN101304741A Water-soluble antiviral agent based on silver-cistine compound and method of preparing thereof
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302500A Vaccine
11/12/2008CN101302252A Extrasin alphal (Tal) analogue, production process and medical use thereof
11/12/2008CN101302247A Method for extracting nosipeptide crude product
11/12/2008CN101302244A Production process of betulinic acid
11/12/2008CN101302203A 6-aryl aminopyrimidine compound and synthetic method thereof
11/12/2008CN101302201A Nitroimidazole derivate for therapy
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN101301466A Medicament for treating AIDS
11/12/2008CN101301465A Fowl transfer factor nano liposomes and preparation thereof
11/12/2008CN101301464A Candy for preventing influenza virus of children
11/12/2008CN101301451A Chinese medicine for treating liver disease
11/12/2008CN101301418A Composition for preventing influenza